Tower Research Capital LLC (Trc) Sellas Life Sciences Group, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,465 shares of SLS stock, worth $24,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,465
Previous 20,889
25.97%
Holding current value
$24,898
Previous $22,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding SLS
# of Institutions
84Shares Held
22.6MCall Options Held
1.3MPut Options Held
59.3K-
Vanguard Group Inc Valley Forge, PA6.65MShares$10.7 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.72MShares$4.37 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.54 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.49MShares$2.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.13MShares$1.81 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $33.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...